Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eksp Onkol ; 8(3): 61-4, 1986.
Artigo em Russo | MEDLINE | ID: mdl-3087732

RESUMO

The inhibitory effect of difluoromethylornithine (DFMO) synthesized by the authors on the activity of the ornithine decarboxylase (ODC) and proliferation of microbial and mammalian cells in vitro was studied. The in vivo growth of ascite plasmocytoma of solid melanoma B-16 cells in mice was also effectively inhibited by DFMO. But the antiproliferative activity of DFMO in solid tumours was substantially lower. Such a decrease in the antitumour activity may be associated with polyamines released from necrotic areas of solid tumours. As the tumour cells "catch" the vitally important metabolites, their effect inside solid tumours is turned against the tumour cells themselves. The second reason of the decrease in the DFMO activity is adsorption of polyamines on the erythrocyte surface.


Assuntos
Antineoplásicos/farmacologia , Inibidores da Ornitina Descarboxilase , Ornitina/análogos & derivados , Animais , Antineoplásicos/uso terapêutico , Bacillus megaterium/efeitos dos fármacos , Divisão Celular/efeitos dos fármacos , Células Cultivadas , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Eflornitina , Escherichia coli/efeitos dos fármacos , Regeneração Hepática/efeitos dos fármacos , Melanoma/tratamento farmacológico , Camundongos , Camundongos Endogâmicos BALB C , Transplante de Neoplasias , Ornitina/farmacologia , Ornitina/uso terapêutico , Plasmocitoma/tratamento farmacológico , Ratos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...